Brief: Viveve Medical Reports Q3 Loss Per Share Of $13.51
Nov 7 (Reuters) - Viveve Medical Inc VIVE.O :
* Q3 LOSS PER SHARE $13.51
* QUARTERLY REVENUE $1.1 MILLION VERSUS $4.8 MILLION
* CASH AND CASH EQUIVALENTS WERE $9.1 MILLION AS OF
SEPTEMBER 30,
2019
Source text: [ID: https://bit.ly/2NpKVHW]
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq